Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Brexpiprazole 2 mg	75
Overall Study	STARTED	Brexpiprazole 3 mg	153
Overall Study	STARTED	Placebo	117
Overall Study	Intent-to-treat Population	Brexpiprazole 2 mg	73
Overall Study	Intent-to-treat Population	Brexpiprazole 3 mg	153
Overall Study	Intent-to-treat Population	Placebo	116
Overall Study	COMPLETED	Brexpiprazole 2 mg	68
Overall Study	COMPLETED	Brexpiprazole 3 mg	130
Overall Study	COMPLETED	Placebo	104
Overall Study	NOT COMPLETED	Brexpiprazole 2 mg	7
Overall Study	NOT COMPLETED	Brexpiprazole 3 mg	23
Overall Study	NOT COMPLETED	Placebo	13

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03548584/flow